Cargando…

Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses

Introduction An increasing number of evidence have reported the association of COVID-19 with increased incidence of thrombotic events. High incidences were initially reported in critically ill COVID-19 patients, but subsequently an increased incidence was also noticed in non-critically ill general w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Jing Yuan, Tan, Chuen Wen, Wong, Wan Hui, Conceicao, Edwin Philip, Ng, Ian Matthias, Cheong, May Anne, Low, Jenny Guek-Hong, Ng, Heng Joo, Lee, Lai Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	331.Pathophysiology of Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330329/ http://dx.doi.org/10.1182/blood-2020-136482

Ejemplares similares

The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients
por: Zheng, Rena, et al.
Publicado: (2021)

Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review
por: Yu, Philip, et al.
Publicado: (2021)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome
por: Coy-Canguçu, Andréa, et al.
Publicado: (2021)

Vaccine-Induced Thrombotic Thrombocytopenia: Novelty Testing in the Diagnostic Work-up?
por: Cacciola, Rossella Rosari, et al.
Publicado: (2021)

Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV
por: Al Raizah, Abdulrahman, et al.
Publicado: (2021)

A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura
por: Naqvi, Syed Mujtaba, et al.
Publicado: (2021)

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation
por: Ratano, Damian, et al.
Publicado: (2020)

COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic
por: Almukhtar, Talat, et al.
Publicado: (2020)

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients
por: Sim, Martha MS, et al.
Publicado: (2020)

Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications
por: Dummer, Wolfgang, et al.
Publicado: (2020)

Hematology Consultations during the COVID-19 Pandemic at a University Medical Center
por: Choi, Daniel C, et al.
Publicado: (2020)

Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry
por: Giannis, Dimitrios, et al.
Publicado: (2020)

Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital
por: Gomez-Rosas, Patricia, et al.
Publicado: (2020)

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19
por: Gerotziafas, Grigoris, et al.
Publicado: (2020)

Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults
por: Mitchell, William Beau, et al.
Publicado: (2020)

Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?
por: Marquez, Félix Gibrant, et al.
Publicado: (2020)

Thrombosis and Mortality in Pregnant Patients with COVID-19
por: Behrens, Elizabeth, et al.
Publicado: (2020)

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study
por: Van Dreden, Patrick, et al.
Publicado: (2020)

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA (2)DS (2)-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study
por: Lee, Yi, et al.
Publicado: (2021)

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021)

Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients?
por: De Vries, Judith Juliana, et al.
Publicado: (2021)

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience
por: Tartari, Carmen Julia J, et al.
Publicado: (2021)

Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination
por: Ge, Melissa, et al.
Publicado: (2021)

The Correlation between Racial/Ethnic Groups, Thrombosis, and Mortality in Hospitalized Patients with COVID-19
por: Rodriguez, Maya, et al.
Publicado: (2021)

Comparison of D-Dimer Level on Mild, Moderate and Severe COVID-19 at Immanuel Hospital Bandung City October 1 (st) - December 31 (st), 2020
por: Gustian, Hary, et al.
Publicado: (2021)

Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction?
por: Ashraf, Bilal, et al.
Publicado: (2021)

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
por: Kaufman, Adrienne, et al.
Publicado: (2021)

COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis
por: Kelliher, Sarah, et al.
Publicado: (2021)

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
por: Stevens, Hannah P, et al.
Publicado: (2021)

Deep Vein Thrombosis after COVID-19 Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2021)

Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
por: Madeeva, Daria V, et al.
Publicado: (2021)

Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities
por: Tan, Chuen Wen, et al.
Publicado: (2021)

Immunosuppressive Treatment Does Not Prevent Humoral and Cellular Virus-Specific Immunity in Heart or Lung Recipients with SARS-CoV-2 Pneumonia
por: Seminari, E., et al.
Publicado: (2021)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eqs163hdauh3dr46ad0schg7u2